These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 32766672)

  • 21. Evaluation of a risk assessment model to predict infection with healthcare facility-onset Clostridioides difficile.
    Tilton CS; Sexton ME; Johnson SW; Gu C; Chen Z; Robichaux C; Metzger NL
    Am J Health Syst Pharm; 2021 Sep; 78(18):1681-1690. PubMed ID: 33954428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection.
    Webb BJ; Subramanian A; Lopansri B; Goodman B; Jones PB; Ferraro J; Stenehjem E; Brown SM
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964789
    [No Abstract]   [Full Text] [Related]  

  • 23. Molecular Epidemiology and Genetic Relatedness of Clostridioides difficile Isolates in Pediatric Oncology and Transplant Patients Using Whole Genome Sequencing.
    Barbar R; Brazelton JN; Carroll KC; Lewis S; Bourdas D; Tembo A; Gluck L; Hakim H; Hayden RT
    Clin Infect Dis; 2023 Feb; 76(3):e1071-e1078. PubMed ID: 35675378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients.
    Alonso CD; Treadway SB; Hanna DB; Huff CA; Neofytos D; Carroll KC; Marr KA
    Clin Infect Dis; 2012 Apr; 54(8):1053-63. PubMed ID: 22412059
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    MacKenzie EL; Murillo C; Bartlett AH; Marrs R; Landon EM; Ridgway JP
    Infect Control Hosp Epidemiol; 2023 Nov; 44(11):1782-1787. PubMed ID: 36658099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and outcomes of Clostridioides difficile infection in liver transplant recipients.
    Kortt NC; Santhakumar C; Davis RJ; Strasser SI; McCaughan GW; Liu K; Majumdar A
    Transpl Infect Dis; 2022 Feb; 24(1):e13758. PubMed ID: 34762768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral Vancomycin Prophylaxis as Secondary Prevention Against Clostridioides difficile Infection in the Hematopoietic Stem Cell Transplantation and Hematologic Malignancy Population.
    Morrisette T; Van Matre AG; Miller MA; Mueller SW; Bajrovic V; Abidi MZ; Benamu E; Kaiser JN; Barber GR; Chase S; Tobin J; Fish DN; Gutman JA
    Biol Blood Marrow Transplant; 2019 Oct; 25(10):2091-2097. PubMed ID: 31255741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clostridioides difficile Infection and Risk of Acute Graft-versus-Host Disease among Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
    Jabr R; El Atrouni W; Shune L; Telfah M; Gao G; He J; Abhyankar S; McGuirk J; Clough L
    Transplant Cell Ther; 2021 Feb; 27(2):176.e1-176.e8. PubMed ID: 33830032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotic exposure and the risk of hospital-acquired diarrhoea and Clostridioides difficile infection: a cohort study.
    Schechner V; Fallach N; Braun T; Temkin E; Carmeli Y
    J Antimicrob Chemother; 2021 Jul; 76(8):2182-2185. PubMed ID: 33969419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterizing
    Magro M; Rosenberg J; Epson E
    Infect Control Hosp Epidemiol; 2021 Mar; 42(3):292-297. PubMed ID: 32993820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for Clostridioides (Clostridium) difficile infection following solid organ transplantation in children.
    Ochfeld E; Balmert LC; Patel SJ; Muller WJ; Kociolek LK
    Transpl Infect Dis; 2019 Oct; 21(5):e13149. PubMed ID: 31332916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clostridioides difficile infection in neurosurgical patients in a national centre over 10 years: less common but associated with longer hospital stays.
    Skally M; Leonard M; O'Halloran PJ; Husien B; Bennett K; Burns K; Dinesh B; Humphreys H; Fitzpatrick F
    Acta Neurochir (Wien); 2023 Dec; 165(12):3585-3592. PubMed ID: 37971621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of Clostridioides difficile Infection Among Asymptomatic, Colonized Patients: A Retrospective Cohort Study.
    Poirier D; Gervais P; Fuchs M; Roussy JF; Paquet-Bolduc B; Trottier S; Longtin J; Loo VG; Longtin Y
    Clin Infect Dis; 2020 May; 70(10):2103-2210. PubMed ID: 31290544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ANTIDEPRESSANT MEDICATIONS ARE ASSOCIATED WITH INCREASED RISK OF HOSPITAL-ACQUIRED CLOSTRIDIOIDES DIFFICILE INFECTION: A POPULATION-BASED STUDY.
    Boustany A; Onwuzo S; Zeid HKA; Almomani A; Asaad I
    Arq Gastroenterol; 2023; 60(3):309-314. PubMed ID: 37792759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Clostridioides difficile with adverse clinical outcomes in patients with acute diverticulitis: A nationwide study.
    Makar M; Makar G; Xia W; Greenberg P; Patel AV
    J Gastroenterol Hepatol; 2021 Apr; 36(4):983-989. PubMed ID: 32870544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Costs Associated with the Treatment of Clostridioides Difficile Infections.
    Sierocka A; Kiersnowska Z; Lemiech-Mirowska E; Marczak M
    Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34300098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes of C difficile infection in solid-organ transplant recipients: The National Inpatient Sample (NIS) 2015-2016.
    Mahatanan R; Tantisattamo E; Charoenpong P; Ferrey A
    Transpl Infect Dis; 2021 Feb; 23(1):e13459. PubMed ID: 32894617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acid Suppression Medications During Hospitalization as a Risk Factor for Recurrence of Clostridioides difficile Infection: Systematic Review and Meta-analysis.
    Mehta P; Nahass RG; Brunetti L
    Clin Infect Dis; 2021 Jul; 73(1):e62-e68. PubMed ID: 32386313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pediatric oncology and stem cell transplant patients with healthcare-associated Clostridium difficile infection were already colonized on admission.
    Al-Rawahi GN; Al-Najjar A; McDonald R; Deyell RJ; Golding GR; Brant R; Tilley P; Thomas E; Rassekh SR; O'Gorman A; Wong P; Turnham L; Dobson S
    Pediatr Blood Cancer; 2019 May; 66(5):e27604. PubMed ID: 30666782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Excess burden associated with Clostridioides difficile infection in haematological patients occurring during hospitalization with induction chemotherapy in the USA.
    Duhalde L; Lurienne L; Wingen-Heimann SM; Guillou L; Buffet R; Bandinelli PA
    J Hosp Infect; 2020 Apr; 104(4):560-566. PubMed ID: 31870888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.